Document is current
Any future updates will be listed below
-
Authors
Ma, Hongrui
Cao, Yashi
Gao, Zizheng
Xu, Zhifei
Yang, Bo
Luo, Peihua
Hu, Yuhuai
He, Qiaojun
-
Funding
Funding for this research was provided by:
Pioneer” and “Leading Goose” R&D Program of Zhejiang province (2024C03144)
National Natural Science Foundation of China (82204516)
- License Information
-
More Information
Article History
Accepted: 15 June 2025
First Online: 28 June 2025
Declarations
:
: Approval of the research protocol by an Institutional Reviewer Board: “Induce fibroblast reprogramming into keratinocyte-like cells for chronic cutaneous wound injury repair”.
: The study was approved by the Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University.
: December 11, 2024.
: DW202412101659.The HEK293FT cells used in this study were purchased from the Shanghai Institute of Biochemistry and Cell Biology. According to information provided by the original source, the cell line was originally established with ethical approval, and informed consent was obtained from the donors at the time of tissue collection. The use of these cells in our study complies with institutional and national ethical standards. Further information regarding the ethical provenance of the HEK293FT cell line is available in the references provided on the official website [].
: Not applicable.
: Not applicable.
: The authors declare no competing interests.
